Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
423
-
Total 13F shares, excl. options
-
171,446,875
-
Shares change
-
+2,398,155
-
Total reported value, excl. options
-
$15,566,292,229
-
Value change
-
+$225,362,433
-
Put/Call ratio
-
1.24%
-
Number of buys
-
200
-
Number of sells
-
-180
-
Price
-
$90.82
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2017
487 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2017.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 423 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171,446,875 shares
of 193,539,047 outstanding shares and own 88.59% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (18,898,699 shares), VANGUARD GROUP INC (14,345,027 shares), JENNISON ASSOCIATES LLC (13,242,773 shares), BlackRock Inc. (11,400,960 shares), PRIMECAP MANAGEMENT CO/CA/ (9,310,224 shares), FMR LLC (9,295,522 shares), SANDS CAPITAL MANAGEMENT, LLC (8,505,481 shares), BAKER BROS. ADVISORS LP (5,905,673 shares), Invesco Ltd. (4,203,916 shares), and STATE STREET CORP (3,896,250 shares).
This table shows the top 423 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.